SCIE期刊CLINICAL NEUROPHARMACOLOGY 2024/2025影響因子:0.816 (CLIN NEUROPHARMACOL) (0362-5664). (PHARMACOLOGY & PHARMACY)(藥理學與藥

補充

Submitted on: 28 October 2002. Revised on: 31 December 2002. Accepted on: 29 January 2003. ___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

出沒

Discrete

Suppository

Submitted on: 19 August 2000. Revised on: 19 October 2000. Accepted on: 04 December 2000. ___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

機制

Submitted on: 28 September 2007. Revised on: 26 January 2008. Accepted on: 12 March 2008. ___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

Cumbersome

Submitted on: 26 September 2001. Revised on: 14 January 2002. Accepted on: 16 February 2002. ___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

盤旋

Submitted on: 13 July 2018. Revised on: 22 October 2018. Accepted on: 18 December 2018. ___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

ostensible

Submitted on: 16 February 2013. Revised on: 13 April 2013. Accepted on: 03 June 2013. ___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS

和平主義者

Prostaglandins

Submitted on: 09 August 2004. Revised on: 02 December 2004. Accepted on: 15 January 2005. ___________________CLINICAL NEUROPHARMACOLOGY---LIPPINCOTT WILLIAMS & WILKINS